{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:28:49Z","timestamp":1788485329054,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jconrel.2022.04.016","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T18:06:12Z","timestamp":1651169172000},"page":"289-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Emerging technologies to increase gastrointestinal transit times of drug delivery systems"],"prefix":"10.1016","volume":"346","author":[{"given":"Gergely","family":"Kali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bernkop-Schn\u00fcrch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.04.016_bb0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1023\/A:1015849700421","article-title":"Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects","volume":"8","author":"Coupe","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0010","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2478\/v10007-009-0021-z","article-title":"Floating drug delivery of a locally acting H2-antagonist: an approach using an in situ gelling liquid formulation","volume":"59","author":"Rohith","year":"2009","journal-title":"Acta Pharma."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.gastro.2019.04.011","article-title":"Reconciliation of recent helicobacter pylori treatment guidelines in a time of increasing resistance to antibiotics","volume":"157","author":"Fallone","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1208\/s12249-013-9945-1","article-title":"Design of an interpolyelectrolyte gastroretentive matrix for the site-specific zero-order delivery of levodopa in Parkinson's disease","volume":"14","author":"Ngwuluka","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0025","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/jps.21562","article-title":"Design and evaluation of polymeric coated minitablets as multiple unit gastroretentive floating drug delivery systems for furosemide","volume":"98","author":"Meka","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0030","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12272-012-0312-7","article-title":"Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note","volume":"35","author":"Ige","year":"2012","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0035","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1248\/cpb.c12-00324","article-title":"Mucoadhesive tablets for controlled release of acyclovir","volume":"60","author":"Ruiz-Caro","year":"2012","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-3659(03)00203-7","article-title":"Expandable gastroretentive dosage forms","volume":"90","author":"Klausner","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/414095","article-title":"Bowel obstruction due to migration of an intragastric balloon necessitating surgical removal before completion of the recommended 6 months","volume":"2012","author":"Mousavi Naeini","year":"2012","journal-title":"Case Rep. Med."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0050","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3109\/02652048.2011.590613","article-title":"Gastroretentive microparticles for drug delivery applications","volume":"28","author":"Adebisi","year":"2011","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11040193","article-title":"Current state and future perspectives on gastroretentive drug delivery systems","volume":"11","author":"Tripathi","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejps.2019.01.012","article-title":"Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique","volume":"129","author":"Grimm","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0065","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijpharm.2016.12.024","article-title":"About the impact of water movement on the permeation behaviour of nanoparticles in mucus","volume":"517","author":"Fabiano","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121147","article-title":"Nanoparticles facing the gut barrier: retention or mucosal absorption? Mechanisms and dependency to nanoparticle characteristics","volume":"609","author":"Zandanel","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0075","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3109\/1061186X.2015.1086359","article-title":"Size selectivity of intestinal mucus to diffusing particulates is dependent on surface chemistry and exposure to lipids","volume":"23","author":"Yildiz","year":"2015","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijpharm.2018.01.018","article-title":"Self-emulsifying peptide drug delivery systems: how to make them highly mucus permeating","volume":"538","author":"Griesser","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0085","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jcis.2022.02.092","article-title":"Reactive oxygen species (ROS) in colloidal systems: are \u201cPEG-free\u201d surfactants the answer?","volume":"616","author":"David Friedl","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0090","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/jcph.1824","article-title":"PEG that reaction: a case series of allergy to polyethylene glycol","volume":"61","author":"Cox","year":"2021","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0095","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejpb.2014.12.021","article-title":"In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration","volume":"97","author":"Inchaurraga","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0100","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0006-3495(01)75844-4","article-title":"Diffusion of macromolecules and virus-like particles in human cervical mucus","volume":"81","author":"Olmsted","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0105","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1021\/la300394c","article-title":"Investigation of the hydration of nonfouling material poly(sulfobetaine methacrylate) by low-field nuclear magnetic resonance","volume":"28","author":"Wu","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejpb.2014.12.024","article-title":"Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles","volume":"97","author":"Pereira de Sousa","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2017.07.061","article-title":"Systematic evaluation of the toxicity and biodistribution of virus mimicking mucus-penetrating DLPC-NPs as oral drug delivery system","volume":"530","author":"Shan","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0120","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.xphs.2019.05.034","article-title":"Design of virus-mimicking polyelectrolyte complexes for enhanced oral insulin delivery","volume":"108","author":"Liu","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejpb.2016.11.037","article-title":"In vivo biodistribution of antihyperglycemic biopolymer-based nanoparticles for the treatment of type 1 and type 2 diabetes","volume":"113","author":"Lopes","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0130","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/jps.24215","article-title":"Improved oral bioavailability of human growth hormone by a combination of liposomes containing bio-enhancers and tetraether lipids and omeprazole","volume":"103","author":"Parmentier","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0135","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.addr.2017.10.004","article-title":"Enzyme decorated drug carriers: targeted swords to cleave and overcome the mucus barrier","volume":"124","author":"Menzel","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejpb.2013.12.012","article-title":"Development and in vivo evaluation of papain-functionalized nanoparticles","volume":"87","author":"M\u00fcller","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpb.2015.01.008","article-title":"Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier","volume":"97","author":"Pereira de Sousa","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcis.2018.07.057","article-title":"Trypsin decorated self-emulsifying drug delivery systems (SEDDS): key to enhanced mucus permeation","volume":"531","author":"Shahzadi","year":"2018","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0155","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1021\/acs.nanolett.6b03515","article-title":"Rotation-facilitated rapid transport of nanorods in mucosal tissues","volume":"16","author":"Yu","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0160","doi-asserted-by":"crossref","first-page":"17520","DOI":"10.1021\/la1029728","article-title":"Thiolated dextran-coated gold nanorods for photothermal ablation of inflammatory macrophages","volume":"26","author":"Choi","year":"2010","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0165","doi-asserted-by":"crossref","first-page":"42492","DOI":"10.1021\/acsami.7b11821","article-title":"Influence of particle geometry on gastrointestinal transit and absorption following Oral administration","volume":"9","author":"Li","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0170","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.1073\/pnas.1508355112","article-title":"Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters","volume":"112","author":"Barr","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0175","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1039\/C5NR07474F","article-title":"Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery","volume":"8","author":"Hu","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0180","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/molecules21010042","article-title":"The prodrug approach: a successful tool for improving drug solubility","volume":"21","author":"Jornada","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0185","doi-asserted-by":"crossref","first-page":"2100219","DOI":"10.1002\/adtp.202100219","article-title":"Alkaline phosphatase: a reliable endogenous partner for drug delivery and diagnostics","volume":"n\/a","author":"Le-Vinh","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2015.01.041","article-title":"Polyethylene imine-6-phosphogluconic acid nanoparticles--a novel zeta potential changing system","volume":"483","author":"Bonengel","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0195","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejpb.2015.01.017","article-title":"Development of phosphorylated nanoparticles as zeta potential inverting systems","volume":"97","author":"Perera","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0200","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1021\/acs.molpharmaceut.9b00355","article-title":"Zeta potential changing polyphosphate nanoparticles: a promising approach to overcome the mucus and epithelial barrier","volume":"16","author":"Akkus","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0205","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijpharm.2016.06.045","article-title":"Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation","volume":"510","author":"Suchaoin","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119299","article-title":"Zeta potential changing nanoemulsions: impact of PEG-corona on phosphate cleavage","volume":"581","author":"Zaichik","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpb.2020.03.004","article-title":"Phosphorylated PEG-emulsifier: powerful tool for development of zeta potential changing self-emulsifying drug delivery systems (SEDDS)","volume":"150","author":"Wolf","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0220","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jcis.2021.01.025","article-title":"Charge reversal self-emulsifying drug delivery systems: a comparative study among various phosphorylated surfactants","volume":"589","author":"Akku\u015f-Da\u011fdeviren","year":"2021","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0225","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejpb.2021.03.012","article-title":"Size shifting of solid lipid nanoparticle system triggered by alkaline phosphatase for site specific mucosal drug delivery","volume":"163","author":"Le-Vinh","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0230","first-page":"ID 2102451","article-title":"Thiolated nanoparticles for biomedical applications: mimicking the workhorses of our body","author":"Hock","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2020.213433","article-title":"Thiolated cyclodextrins: new perspectives for old excipients","volume":"420","author":"Hussain Asim","year":"2020","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0240","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.addr.2019.04.007","article-title":"Thiolated polymers: bioinspired polymers utilizing one of the most important bridging structures in nature","volume":"151-152","author":"Leichner","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0245","doi-asserted-by":"crossref","first-page":"14357","DOI":"10.1038\/s41598-018-32699-2","article-title":"Insights into gold nanoparticles as a mucoadhesive system","volume":"8","author":"Ouellette","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0250","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejps.2018.06.032","article-title":"Synthesis of thiolated, PEGylated and POZylated silica nanoparticles and evaluation of their retention on rat intestinal mucosa in vitro","volume":"122","author":"Ways","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0255","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2009.04.021","article-title":"Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery","volume":"137","author":"Shen","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0260","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1021\/acs.biomac.1c00776","article-title":"In vitro investigation of thiolated chitosan derivatives as mucoadhesive coating materials for solid lipid nanoparticles","volume":"22","author":"Wibel","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0265","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1080\/10717544.2017.1391890","article-title":"Xiao, N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations","volume":"24","author":"Tian","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0270","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.addr.2019.04.007","article-title":"Thiolated polymers: bioinspired polymers utilizing one of the most important bridging structures in nature","volume":"151-152","author":"Leichner","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/polym12061259","article-title":"Less reactive thiol ligands: key towards highly mucoadhesive drug delivery systems","volume":"12","author":"Shahzadi","year":"2020","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0280","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2015.01.004","article-title":"Mucus permeating thiomer nanoparticles","volume":"97","author":"K\u00f6llner","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0285","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nrd1576","article-title":"Cyclodextrin-based pharmaceutics: past, present and future","volume":"3","author":"Davis","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0290","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10311-018-0763-2","article-title":"Cyclodextrins, from molecules to applications","volume":"16","author":"Crini","year":"2018","journal-title":"Environ. Chem. Lett."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0295","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijpharm.2017.10.054","article-title":"Development of pre-activated \u03b1-cyclodextrin as a mucoadhesive excipient for intra-vesical drug delivery","volume":"534","author":"Ijaz","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0300","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2217\/fmb-2018-0288","article-title":"Mucoadhesive S-protected thiolated cyclodextrin-iodine complexes: a promising strategy to prolong mucosal residence time of iodine","volume":"14","author":"Asim","year":"2019","journal-title":"Future Microbiol."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.carbpol.2015.06.073","article-title":"Synthesis and characterization of thiolated beta-cyclodextrin as a novel mucoadhesive excipient for intra-oral drug delivery","volume":"132","author":"Ijaz","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0310","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1016\/j.xphs.2016.04.021","article-title":"Thiolated alpha-Cyclodextrin: the invisible choice to prolong ocular drug residence time","volume":"105","author":"Ijaz","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0315","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.xphs.2016.03.009","article-title":"Thiolated cyclodextrin: development of a mucoadhesive vaginal delivery system for acyclovir","volume":"105","author":"Ijaz","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0320","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jcis.2018.07.062","article-title":"S-protected thiolated cyclodextrins as mucoadhesive oligomers for drug delivery","volume":"531","author":"Asim","year":"2018","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117202","article-title":"Inclusion complex based on N-acetyl-L-cysteine and arginine modified hydroxypropyl-\u03b2-cyclodextrin for oral insulin delivery","volume":"252","author":"Li","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0330","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.2147\/IJN.S153226","article-title":"Non-ionic thiolated cyclodextrins - the next generation","volume":"13","author":"Moghadam","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0335","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1021\/acsami.9b21335","article-title":"Per-6-thiolated cyclodextrins: a novel type of permeation enhancing excipients for BCS class IV drugs","volume":"12","author":"Asim","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0340","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1021\/cr970012b","article-title":"Methods for selective modifications of cyclodextrins","volume":"98","author":"Khan","year":"1998","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119040","article-title":"Tetradeca-thiolated cyclodextrins: highly mucoadhesive and in-situ gelling oligomers with prolonged mucosal adhesion","volume":"577","author":"Hussain Asim","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0350","series-title":"Per-thiolated b-Cyclodextrin as Mucoadhesive with Prolonged Intestinal Residence Time","author":"Kali","year":"2021"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0355","series-title":"Unpublished Results","author":"Llorenz","year":"2021"},{"key":"10.1016\/j.jconrel.2022.04.016_bb0360","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijbiomac.2019.02.092","article-title":"S-protected gellan gum: decisive approach towards mucoadhesive antimicrobial vaginal films","volume":"130","author":"Jalil","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0365","article-title":"Synthesis and characterization of thiol modified beta cyclodextrin, its biocompatible analysis and application as a modified release carrier of ticagrelor","volume":"16","author":"Zaman","year":"2020","journal-title":"Biomed. Mater."},{"key":"10.1016\/j.jconrel.2022.04.016_bb0370","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.2042-7158.1998.tb06171.x","article-title":"Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites","volume":"50","author":"Akiyama","year":"1998","journal-title":"J. Pharm. Pharmacol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922002103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922002103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:25:02Z","timestamp":1759163102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922002103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":74,"alternative-id":["S0168365922002103"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.04.016","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging technologies to increase gastrointestinal transit times of drug delivery systems","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}